Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit
In conclusion, we reported the real-life experience of our pediatric oncology unit during the pandemic period.EXPERT OPINION: Starting from the data available in literature, and our experience, showing the rarity of severe COVID-19 disease in pediatric patients with solid tumors, we recommend carefully tailoring all the oncological treatments (chemotherapy/targeted therapy/stem cell transplantation/radiotherapy). The aim is the preservation of the treatment's timing, balanced with an evaluation of possible severe COVID-19 disease.PMID:37712347 | DOI:10.1080/14737140.2023.2245148
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Authors: Olga Nigro Chiara Oltolini Federica Barzaghi Caterina Uberti Foppa Maria Pia Cicalese Maura Massimino Elisabetta Schiavello Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Children | Coronavirus | Covid Vaccine | COVID-19 | Italy Health | Pandemics | Pediatrics | Respiratory Medicine | SARS | Stem Cell Therapy | Stem Cells | Transplants | Vaccines